Michael Dunn
Internal Medicine · Omaha, NENPI 1972796381
Payments from drug & device makers
Across 636 payments — averaging $12,369 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Modernatx, Inc.$4.7M
- Pfizer$2.4M
- Eli Lilly$260K
- Ferring International Pharmascience Center US$199K
- GSK$161K
- Ferring Pharmaceuticals AS$85K
- plus $55K from 4 others
Across 6 payments — averaging $33,217 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Eli Lilly$199K
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Modernatx, Inc. | 344 | $4,738,572 |
| Pfizer | 203 | $2,366,685 |
| Eli Lilly | 12 | $260,284 |
| Ferring International Pharmascience Center US | 15 | $199,188 |
| GSK | 26 | $161,493 |
| Ferring Pharmaceuticals AS | 15 | $85,059 |
| AstraZeneca | 4 | $23,857 |
| Dr.reddy's Laboratories,inc. | 8 | $14,058 |
| Phathom Pharmaceuticals, Inc. | 6 | $13,984 |
| Paratek Pharmaceuticals, Inc. | 3 | $3,308 |
How this compares
$7,866,487 in reported general payments places this provider in the 95th percentile of 570 internal medicine providers in Nebraska.
Other internal medicine in Omaha
- Joel MichalskiOmaha$1.6M
- Ariana BauerOmaha$1.5M
- David CrockettOmaha$821K
- Bryant EnglandOmaha$637K
- Adam BurdorfOmaha$313K
- Brian BoerOmaha$142K
- David JasperOmaha$128K
- Andrew RorieOmaha$61K
- Mohamed AhmedOmaha$57K
- Mridula KrishnanOmaha$56K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.